[1] 中国抗癌协会肝癌专业委员会转化治疗协作组. 原发性肝癌转化及围手术期治疗中国专家共识(2024版)[J]. 中华消化外科杂志, 2024, 23(4): 492-513.
[2] PENG Z, FAN W, ZHU B, et al.Lenvatinib combined with transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma: a phase Ⅲ, Randomized Clinical Trial (LAUNCH)[J]. J Clin Oncol, 2023, 41(1): 117-127.
[3] GRANIERI S, BRACCHETTI G, KERSIK A, et al.Preoperative indocyanine green (ICG) clearance test: Can we really trust it to predict post hepatectomy liver failure? A systematic review of the literature and Meta-analysis of diagnostic test accuracy[J]. Photodiagnosis Photodyn Ther, 2022, 40: 103170.
[4] PRIMAVESI F, MAGLIONE M, CIPRIANI F, et al.E-AHPBA-ESSO-ESSR Innsbruck consensus guidelines for preoperative liver function assessment before hepatectomy[J]. The British journal of surgery, 2023, 110(10): 1331-1347.
[5] 海峡两岸医药卫生交流协会肿瘤防治专家委员会. 肝癌肝切除围手术期管理中国专家共识(2021年版)[J]. 中华肿瘤杂志,2021,43(4): 414-430.
[6] 方驰华, 王晓颍, 刘允怡. 计算机辅助联合吲哚菁绿分子荧光影像技术在肝脏肿瘤诊断和手术导航中应用指南(2019版)[J]. 中国实用外科杂志, 2019, 39(07): 641-50+54.
[7] SUGIOKA A, KATO Y, TANAHASHI Y.Systematic extrahepatic Glissonean pedicle isolation for anatomical liver resection based on Laennec's capsule: proposal of a novel comprehensive surgical anatomy of the liver[J]. J Hepatobiliary Ppancreat Ssc, 2017, 24(1): 17-23.
[8] LI B, QIU J, ZHENG Y, et al.Conversion to resectability using transarterial chemoembolization combined with hepatic arterial infusion chemotherapy for initially unresectable hepatocellular carcinoma[J]. Ann Surg Open, 2021, 2(2): e057.
[9] LIU D, MU H, LIU C, et al.Sintilimab, bevacizumab biosimilar, and HAIC for unresectable hepatocellular carcinoma conversion therapy: a prospective, single-arm phase II trial[J]. Neoplasma, 2023, 70(6): 811-818. |
